NCT06075394View on ClinicalTrials.gov

Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis

CompletedOBSERVATIONAL
Enrollment

9,294

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

October 1, 2023

Conditions
Psoriasis
Trial Locations (1)

710032

Dermatology Derpartment of Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT06075394 - Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis | Biotech Hunter | Biotech Hunter